Representative before the EPO

Employment test 51 - 200 employees
Company dna j a kemp
no operation time available
1113.55
Headquarter in London and 4 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Gail Wilson McCluskie has worked on the following 7 EPO patent applications which have been published in the last five years:

EP11748807

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING ADVERSE OR DELETERIOUS SEQUELLAE OF TRAUMATIC BRAIN INJURY

IPC classification:
A61K 31/7004, A61P 25/28
Applicant:
Wisconsin Alumni Research Foundation (WARF)
Agent:
Multiple attorneys, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12186689

Nitrogeneous heterocyclic derivative and medicine containing the same as an active ingredient

IPC classification:
A61K 31/444, A61K 31/4468, A61K 45/00, A61P 11/06, A61P 29/00, A61P 31/04, A61P 31/18, A61P 37/00, A61P 37/06, A61P 43/00, C07D 211/58
Agent:
Multiple attorneys, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11818261

METHOD FOR PRODUCING DISPERSION OF RUTILE-TYPE TITANIUM OXIDE PARTICLES

IPC classification:
B01J 31/38, C01G 23/047, C01G 23/053, C08K 3/20, C08L 101/00, C09C 1/36, C09D 17/00, G02B 1/04
Applicant:
Sakai Chemical Industry Co Ltd
Agent:
Multiple attorneys, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP10859577

METHOD FOR PRODUCING BIOACTIVE AGENT, BIOACTIVE AGENT PRODUCED THEREBY, COSMETIC, FRESHNESS-MAINTAINING AGENT, GROWTH PROMOTION AGENT, SOIL CONDITIONING AGENT, AND PHARMACEUTICAL STOCK SOLUTION

IPC classification:
A23B 4/027, A23B 7/157, A23L 3/358, A61K 8/19, A61K 8/67, A61K 31/122, A61K 31/355, A61K 31/375, A61K 33/06, A61K 33/26, A61P 1/16, A61P 3/10, A61P 35/00, A61P 37/08, A61Q 7/00, A61Q 19/00, C05D 5/00, C09K 17/02, C09K 17/40
Agent:
Multiple attorneys, J A Kemp
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11715111

LITHUM/CARBON MONOFLUORIDE BATTERIES WITH ELECTROLYTES BASED ON ORGANOSILICON COMPOUNDS

IPC classification:
H01M 2/16, H01M 4/38, H01M 4/587, H01M 10/052, H01M 10/0569
Applicant:
Wisconsin Alumni Research Foundation (WARF)
Agent:
Multiple attorneys, J A Kemp
Status:
PATENT GRANTED
EP13154050

Aminocarboxylic acid derivative and medical use thereof

IPC classification:
A61K 31/12, A61K 31/166, A61K 31/197, A61K 31/215, A61K 31/397, A61K 31/4035, A61K 31/41, A61K 31/437, A61K 31/4409, A61K 31/4412, C07C 229/14
Agent:
Multiple attorneys, J A Kemp
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature